[go: up one dir, main page]

NO20000301D0 - Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasoeytiske blandinger som inneholder den - Google Patents

Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasoeytiske blandinger som inneholder den

Info

Publication number
NO20000301D0
NO20000301D0 NO20000301A NO20000301A NO20000301D0 NO 20000301 D0 NO20000301 D0 NO 20000301D0 NO 20000301 A NO20000301 A NO 20000301A NO 20000301 A NO20000301 A NO 20000301A NO 20000301 D0 NO20000301 D0 NO 20000301D0
Authority
NO
Norway
Prior art keywords
carbazolyloxy
methoxyphenoxy
ethylamino
propanol
preparation
Prior art date
Application number
NO20000301A
Other languages
English (en)
Other versions
NO313588B1 (no
NO20000301L (no
Inventor
Erhard Reinholz
Peter Beyer
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20000301L publication Critical patent/NO20000301L/no
Publication of NO20000301D0 publication Critical patent/NO20000301D0/no
Publication of NO313588B1 publication Critical patent/NO313588B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20000301A 1997-07-22 2000-01-21 Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte forfremstilling derav og farmasöytiske blandinger som inneholder den NO313588B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (en) 1997-07-22 1997-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
PCT/EP1998/004475 WO1999005105A1 (en) 1997-07-22 1998-07-18 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it

Publications (3)

Publication Number Publication Date
NO20000301L NO20000301L (no) 2000-01-21
NO20000301D0 true NO20000301D0 (no) 2000-01-21
NO313588B1 NO313588B1 (no) 2002-10-28

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000301A NO313588B1 (no) 1997-07-22 2000-01-21 Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte forfremstilling derav og farmasöytiske blandinger som inneholder den

Country Status (31)

Country Link
EP (2) EP0893440A1 (no)
JP (1) JP2001510824A (no)
KR (1) KR100336229B1 (no)
CN (1) CN1125047C (no)
AR (1) AR015133A1 (no)
AT (1) ATE236123T1 (no)
AU (1) AU740453B2 (no)
BR (1) BR9810776A (no)
CA (1) CA2296637C (no)
CZ (1) CZ296947B6 (no)
DE (1) DE69812964T2 (no)
DK (1) DK1000027T3 (no)
ES (1) ES2195366T3 (no)
HR (1) HRP980406A2 (no)
HU (1) HUP0003198A3 (no)
IL (1) IL133677A (no)
MA (1) MA26523A1 (no)
MY (1) MY117734A (no)
NO (1) NO313588B1 (no)
NZ (1) NZ502136A (no)
PE (1) PE96999A1 (no)
PL (1) PL191602B1 (no)
PT (1) PT1000027E (no)
RU (1) RU2202542C2 (no)
SI (1) SI1000027T1 (no)
TR (1) TR200000148T2 (no)
TW (1) TW505631B (no)
UY (1) UY25108A1 (no)
WO (1) WO1999005105A1 (no)
YU (1) YU2200A (no)
ZA (1) ZA986475B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003528914A (ja) * 2000-04-03 2003-09-30 エフ．ホフマン−ラ ロシュ アーゲー カルベジロールの濃縮溶液
EP1655285A1 (en) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Method for preparation of a crystalline form of carvedilol (form II)
KR20030017569A (ko) 2000-06-28 2003-03-03 테바 파마슈티컬 인더스트리즈 리미티드 카르베딜올
DE60212130D1 (en) * 2001-07-13 2006-07-20 Smithkline Beecham Corp Carvedilolpolymorph
US20050019399A1 (en) 2001-09-21 2005-01-27 Gina Fischer Controlled release solid dispersions
ES2291503T3 (es) * 2001-09-28 2008-03-01 F. Hoffmann-La Roche Ag Formas pseudopolimorficas de carvedilol.
HRP20040673A2 (en) 2002-01-15 2005-06-30 Teva Pharmaceutical Industries Ltd. Crystalline solids of carvedilol and processes for their preparation
WO2003092622A2 (en) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
JP2005533823A (ja) * 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド リン酸カルベジロール塩および／またはその溶媒和物、対応する組成物、および／または治療方法
CA2492084A1 (en) 2002-06-27 2004-01-08 Sb Pharmco Puerto Rico Inc. Carvedilol hydobromide
US20040151772A1 (en) * 2002-11-08 2004-08-05 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
EP1615888A1 (en) * 2003-04-21 2006-01-18 Matrix Laboratories Ltd Process for the preparation of carvedilol form-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (en) * 2003-11-25 2009-05-27 Sb Pharmco Inc CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
PT1838670E (pt) * 2004-12-09 2009-12-18 Zach System Spa Processo para a preparação de carvedilol e seus enantiómeros
KR20070088507A (ko) * 2005-06-09 2007-08-29 테바 파마슈티컬 인더스트리즈 리미티드 카베딜올의 결정질 형태 및 이것의 제조 방법
EP1991527A2 (en) 2006-06-28 2008-11-19 Teva Pharmaceutical Industries Ltd Polymorphous forms of carvedilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
AU2008258596B2 (en) 2007-06-04 2013-02-14 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
WO2010089132A1 (en) 2009-02-06 2010-08-12 Egalet A/S Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
ES2195366T3 (es) 2003-12-01
PL338432A1 (en) 2000-11-06
MA26523A1 (fr) 2004-12-20
BR9810776A (pt) 2000-09-19
ATE236123T1 (de) 2003-04-15
TW505631B (en) 2002-10-11
JP2001510824A (ja) 2001-08-07
KR20010022097A (ko) 2001-03-15
DK1000027T3 (da) 2003-07-21
EP1000027B1 (en) 2003-04-02
DE69812964D1 (de) 2003-05-08
RU2202542C2 (ru) 2003-04-20
KR100336229B1 (ko) 2002-05-09
AU8631998A (en) 1999-02-16
CA2296637A1 (en) 1999-02-04
YU2200A (sh) 2002-03-18
ZA986475B (en) 2000-01-21
NZ502136A (en) 2002-05-31
EP1000027A1 (en) 2000-05-17
PT1000027E (pt) 2003-07-31
DE69812964T2 (de) 2004-03-04
HRP980406A2 (en) 1999-04-30
WO1999005105A1 (en) 1999-02-04
CZ2000221A3 (cs) 2000-05-17
CN1264366A (zh) 2000-08-23
NO313588B1 (no) 2002-10-28
IL133677A0 (en) 2001-04-30
EP0893440A1 (en) 1999-01-27
CA2296637C (en) 2005-11-15
MY117734A (en) 2004-07-31
HUP0003198A2 (en) 2001-03-28
CZ296947B6 (cs) 2006-08-16
HK1029339A1 (en) 2001-03-30
HUP0003198A3 (en) 2002-10-28
PE96999A1 (es) 1999-10-12
TR200000148T2 (tr) 2000-07-21
NO20000301L (no) 2000-01-21
PL191602B1 (pl) 2006-06-30
AU740453B2 (en) 2001-11-01
SI1000027T1 (en) 2003-10-31
UY25108A1 (es) 2000-12-29
AR015133A1 (es) 2001-04-18
CN1125047C (zh) 2003-10-22
IL133677A (en) 2004-06-01

Similar Documents

Publication Publication Date Title
NO20000301L (no) Termodynamisk stabil modifikasjon av 1-(4-karbazolyloksy)-3- [2-(2-metoksyfenoksy)etylamino]-2-propanol, fremgangsmåte for fremstilling derav og farmasøytiske blandinger som inneholder den
DK1202965T3 (da) Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
EE200200409A (et) 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
CO5160257A1 (es) La n-piperidino-5-(4-bromofenil)-1-(2,4-diclorofenil)-4-etilpirazol-3-carboxamida, sus sales, su preparacion y las composiciones farmaceuticas que la contienen
IS1850B (is) Kristölluð a-fjölgervingsmynd af indól afleiðu, notkun hennar, aðferð til framleiðslu og lyfjaefnablanda
NO20005430L (no) 1-[(1-substituerte-4-piperidinyl)metyl]-4-piperidinderivater, fremgangsmåter for fremstilling av disse, medisinske preparater inneholdende disse, og mellomprodukter for disse forbindelser
HUP9700777A3 (en) Estrogenical 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole derivatives, preparation and use thereof and pharmaceutical compositions containing these compounds
NO20031619L (no) Substituerte indoler, farmasöytiske blandinger inneholdende slike indoler og deres anvendelse som PPAR-gamma-bindende midler
NO20024891L (no) Farmasöytiske sammensetninger
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
DK1036794T3 (da) 2-Aryl-8-oxodihydropurinderivater, fremgangsmåde til fremstilling af samme, medicinske præparater indeholdende samme og mellemprodukter deraf
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
NO984290L (no) Farmas°ytisk nyttige forbindelser
ZA200303113B (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them.
PL370412A1 (en) Pseudopolymorphic forms of carvedilol
HUP0201338A2 (en) Novel indole derivatives, pharmaceutical compositions containing them and their use
HUP0202821A3 (en) Crystalline polymorphic hemisulphate of pharmaceutical indole derivative, its use and preparation and pharmaceutical compositions containing thereof
EE04778B1 (et) Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200100417A (et) (1-fenatsüül-3-fenüül-3-piperidinüületüül)piperidiini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE200100499A (et) Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
HUP0004432A3 (en) Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it
NO20005158L (no) FremgangsmÕte for fremstilling av R-(+)-6-karboksamido-3-N- metylamino-1,2,3,4-tetrahydrokarbazol
HUP0000586A3 (en) 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and pharmaceutical compositions containing them
DK1105388T3 (da) N-substituerede azabicycloheptan-derivater, fremstilling og anvendelse heraf